Stuart Therapeutics

Stuart Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to researching and developing unique synthetic peptides as potential treatments for ophthalmic diseases. Stuart Therapeutics was founded to bring a completely new perspective to the development of therapies for difficult-to-treat ophthalmic conditions. Our team brings a variety of proven clinical, drug development, operational, and collaboration skills to support our enterprise.